Welcome to our dedicated page for Sharps Tech news (Ticker: STSS), a resource for investors and traders seeking the latest updates and insights on Sharps Tech stock.
Sharps Technology Inc. reports developments for a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy. Company updates center on SOL treasury holdings, staking activity, validator relationships, custody and trading infrastructure, and collaborations with digital asset service providers including Coinbase, BitGo and The Tie.
Sharps Technology news also covers financial results, capital allocation actions such as share repurchase authorization, advisor warrant lock-up arrangements, shareholder and capital-market matters, and changes to its operating profile as the company maintains its medical device distribution business alongside digital asset treasury activity.
Sharps Technology has signed a $200 million, 5-year syringe sales agreement with Nephron Pharmaceuticals and an asset purchase agreement (APA) to acquire InjectEZ's syringe manufacturing assets for $35 million. This acquisition, expected to close within 60 days, will establish a dedicated prefillable syringe manufacturing plant in West Columbia, SC. The facility aims to start production by Q2 2025, projecting $37 million in revenue in the first 12 months. This deal expands Sharps' manufacturing capacity in the U.S. and Europe and positions the company for growth in the copolymer prefillable syringe market.
Sharps Technology (NASDAQ: STSS) CEO Robert Hayes addresses shareholders about the impact of recent FDA actions and tariffs. The FDA raised quality concerns over Chinese syringes in November 2023, leading to recalls and warnings in early 2024. The Biden Administration increased tariffs on Chinese syringes from 0% to 50% in May 2024. Sharps Technology, with its high-quality syringe products like SecureGard and SoloGard, is poised to fill the supply gap. The company manufactures in Hungary and plans to add a US facility. Sharps has also formed partnerships with Roncadelle Operations and Owens & Minor to expand market reach and distribution. These steps are expected to drive revenue growth and market presence.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.